Although cisplatin, paclitaxel, and 5-fluorouracil promoted the clonal expansion of tumor-specific CD8+ T cells, an inadequate magnitude of an immune response was eventually manifested, owing to the increased expression of microenvironment-related IDO (Munn and Mellor, 2016). Here, CD8A is linked to neoplasm.